Hepion Pharmaceuticals, Inc. (HEPA)
NASDAQ: HEPA · Real-Time Price · USD
0.2875
-0.0025 (-0.86%)
At close: Apr 25, 2025, 4:00 PM
0.2875
0.00 (0.00%)
Pre-market: Apr 28, 2025, 6:41 AM EDT

Hepion Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Selling, General & Admin
7.59.6210.3510.018.15
Upgrade
Research & Development
11.8535.6433.2720.412
Upgrade
Operating Expenses
19.3545.2643.6230.420.15
Upgrade
Operating Income
-19.35-45.26-43.62-30.4-20.15
Upgrade
Interest Expense
-1.25-0.01-0.01-0.01-0.03
Upgrade
Other Non Operating Income (Expenses)
-3.17----0.01
Upgrade
EBT Excluding Unusual Items
-23.76-45.27-43.63-30.41-20.18
Upgrade
Impairment of Goodwill
---1.87--
Upgrade
Other Unusual Items
7.6-0.880.41-2.31-0.14
Upgrade
Pretax Income
-16.16-49.34-45.08-32.72-20.32
Upgrade
Income Tax Expense
-2.97-0.41-2.88-0.03
Upgrade
Net Income
-13.19-48.93-42.2-32.72-20.35
Upgrade
Preferred Dividends & Other Adjustments
--3.14-0.01
Upgrade
Net Income to Common
-13.19-48.93-45.34-32.72-20.36
Upgrade
Shares Outstanding (Basic)
0000-
Upgrade
Shares Outstanding (Diluted)
0000-
Upgrade
Shares Change (YoY)
54.75%4.18%8.45%--
Upgrade
EPS (Basic)
-107.35-616.07-594.75-465.52-
Upgrade
EPS (Diluted)
-107.35-616.07-594.75-465.52-
Upgrade
Free Cash Flow
-18.22-40.9-34.98-31.35-16.25
Upgrade
Free Cash Flow Per Share
-148.23-515.05-458.85-446.07-
Upgrade
EBITDA
-19.32-45.19-43.54-30.32-20.11
Upgrade
D&A For EBITDA
0.030.070.080.090.03
Upgrade
EBIT
-19.35-45.26-43.62-30.4-20.15
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q